The board of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced that Mr. LI Xuechen has been appointed as the chairman of the nomination committee of the Company; Mr. TANG Jianxin ('Mr. Tang') has been appointed as a member of the Nomination Committee; and Ms. XIANG Ling (`Ms. Xiang') has been appointed as a member of the audit committee of the Company with effect from 3 October 2022. The board (the ``Board') of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has received the written resignations tendered by Mr. Eddy HUANG (`Mr. Huang''), a non-executive Director, and Mr. ZHAO Dayao (`Mr. Zhao'), an independent non-executive Director, with effect from 30 September 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.4 HKD | +0.32% | -5.05% | -0.95% |
16/05 | YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Proposes Special Dividend | CI |
08/05 | Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.95% | 1.06B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 1558 Stock
- News YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
- Yichang Hec Changjiang Pharmaceutical Co., Ltd. Announces Committee Appointments